Procaine in Malignant Hyperpyrexia
- 2 December 1972
- Vol. 4 (5839) , 526-528
- https://doi.org/10.1136/bmj.4.5839.526
Abstract
The caffeine contracture of normal human muscle, which has been used as a model for malignant hyperpyrexia, is greatly potentiated by halothane. Prior administration of procaine markedly reduces the halothane-potentiated caffeine contracture, and procaine given at the height of the contracture induces relaxation. Lignocaine, on the other hand, produces a variable response and sometimes increases the contracture. The muscle from a patient with an inherited susceptibility to malignant hyperpyrexia contracted spontaneously with halothane alone, and this contracture was reversed by procaine. These experiments support the therapeutic use of procaine in malignant hyperpyrexia.Keywords
This publication has 15 references indexed in Scilit:
- An In-vitro Model of Anesthetic Hypertonic Hyperpyrexia, Halothane—Caffeine-induced Muscle ContracturesAnesthesiology, 1971
- Anaesthetic-induced Malignant Hyperpyrexia: A Suggested Method of TreatmentBMJ, 1971
- Halothane-induced muscle contracture as a cause of hyperpyrexia.1971
- Treatment of an˦sthetic-induced malignant hyperpyrexiaThe Lancet, 1971
- METABOLIC ERROR OF MUSCLE METABOLISM AFTER RECOVERY FROM MALIGNANT HYPERTHERMIAThe Lancet, 1970
- Malignant hyperthermia: Aetiology unknownCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1970
- BIOCHEMICAL CHANGES IN MALIGNANT HYPERPYREXIAThe Lancet, 1970
- MYOPATHY AND MALIGNANT HYPERPYREXIAThe Lancet, 1970
- Malignant Hyperpyrexia during Anaesthesia: Possible Association with Subclinical MyopathyBMJ, 1970
- The Mechanism of the Action of Caffeine on Sarcoplasmic ReticulumThe Journal of general physiology, 1968